Inovio Pharmaceuticals, Inc.INONASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-12.76%
↓ 163% below average
Average (9y)
20.34%
Historical baseline
Range
High:164.46%
Low:-53.81%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -12.76% |
| 2023 | -53.81% |
| 2022 | -24.71% |
| 2021 | 164.46% |
| 2020 | 7.08% |
| 2019 | -7.60% |
| 2018 | -3.36% |
| 2017 | 11.12% |
| 2016 | 53.50% |
| 2015 | 69.50% |